Prolacta Bioscience Appoints David Steinberg as Chief Financial Officer

DUARTE, Calif., June 7, 2022 /PRNewswire/ — Prolacta BioscienceĀ®, the world’s leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, announced today that top-ranked analyst David Steinberg has been appointed as chief financial…